Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02663830Phase 2Completed
Phase 2, randomised, open-label trial of ASP-001 in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Ain Shams University. Primary endpoint: Clinical pregnancy rate at 6 weeks. Started Jan 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02663830.